- Global Pharma News & Resources

Pain Management Devices Market Overview 2020, In-depth analysis with Impact of COVID-19, Types, Opportunities, Revenue and Forecast 2026

Pune, Maharashtra, India, September 16 2020 (Wiredrelease) Allied Analytics –:Global Pain management devices market size was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, growing at a CAGR of 6.7% from 2019 to 2026.

Pain management is a branch of medical science, which eases the suffering of patients suffering from chronic pain or acute pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation (TENS) devices, intrathecal infusion pumps, external infusion pumps, and others are widely used in management of chronic pain. 

The Neuromodulation and Neurostimulation Devices segment dominated the market

Based on product, the neuromodulation and neurostimulation devices segment held the largest share in 2018, contributing to more than three-fifths of the global pain management devices market. This is attributed to the rise in adoption of neurostimulation & neuromodulation devices for management of pain due to prevalence of neurological disorders such as Parkinson’s disease and migraine. On the other hand, the analgesic infusion pumps segment is expected to register the fastest CAGR of 8.2% during the forecast period, owing to the increase in prevalence of chronic diseases, rise in aging population, technological innovations in analgesic pumps, and surge in adoption of infusion pumps.

Download Free Sample Report @

Cancer Pain segment to portray fastest growth by 2026

Based on application, the cancer pain segment is expected to register the fastest CAGR of 8.3% during the forecast period. This is attributed to rise in incidence of different forms of cancer and increase in adoption of cancer pain drugs. In addition, upsurge in geriatric population and wide availability of pain management devices drive the market growth. However, the neuropathic pain segment dominated the global pain management devices market in 2018, accounting for nearly one-third of the market. The increase in number of target population, rise in number of risk factors such as diabetes, HIV, multiple sclerosis, & cancer, technological advancement in pain management devices, and surge in demand for pain management devices for management of neuropathic pain are driving the growth of the segment.

North America to lead throughout the forecast period

The market across the North America region held the largest share in 2018, accounting for more than two-fifths of the market. The region is expected to maintain its dominance throughout the forecast period, owing to the rise in prevalence of chronic pain, increase in demand for pain management devices, presence of advanced healthcare facilities with trained medical professionals, and higher in number of R&D activities to develop innovative device. On the other hand, the Asia-Pacific region is anticipated to register the fastest CAGR of 8.5% during the forecast period. Improvement in healthcare infrastructure, availability of pain management devices, surge in healthcare reforms, and technological advancements in the field of healthcare are the major factors driving the growth in the region.

For Purchase Enquiry at:

Major market players

B Braun Melsungen AGBoston Scientific CorpBaxter International IncAbbott LaboratoriesJohnson & Johnson (Codman And Shurtleff, Inc.)DJO Global LLCMedtronic PlcKimberly Clark CorporationPfizer, IncStryker Corp

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 16-Sep-2020